A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma

Annual Review of Medicine
Arturo Molina

Abstract

The anti-CD20 monoclonal antibody rituximab, first approved for clinical use in 1997, has changed the standard of care for many patients with non-Hodgkin's lymphoma (NHL). Recent data from large randomized clinical trials confirm that the addition of rituximab to standard chemotherapy regimens (chemoimmunotherapy) improves both response rates and survival outcomes in patients with follicular NHL and diffuse large B cell lymphoma (DLBCL), the two most common subtypes of NHL. Population-based analyses have found substantial improvements in NHL survival over the past decade; studies indicate that rituximab has favorably altered the long-term prognosis of follicular NHL and DLBCL patients. This review discusses the clinical development of rituximab-based therapies for patients with low-grade or follicular NHL and newly diagnosed DLBCL, highlighting recent key randomized trials with a focus on survival outcomes.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jan 1, 1997·Kidney & Blood Pressure Research·M E Safar, G M London
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Aug 12, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L D PiroV Jain
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A DavisR Levy
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Jan 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigDebra A Welker
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William WierdaMichael Keating
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J KeatingHagop Kantarjian
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FeugierB Coiffier
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Oct 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I FisherThomas P Miller
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Yu-Ming ChangChristopher P Evans
Apr 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael HeroldUNKNOWN East German Study Group Hematology and Oncology Study

❮ Previous
Next ❯

Citations

Jul 14, 2011·Applied Microbiology and Biotechnology·Meng GongJingqiu Cheng
Aug 7, 2009·Cancer Immunology, Immunotherapy : CII·Pina M CardarelliDavid J King
Feb 25, 2011·Cancer Immunology, Immunotherapy : CII·Joseph M TuscanoRobert T O'Donnell
Oct 31, 2008·Current Hypertension Reports·Alan H Gradman, Rehka Pinto
Mar 6, 2009·Medical Oncology·Barbara Jezersek Novaković, Ana Benigar
Dec 4, 2012·Dermatology and Therapy·Labib R ZakkaA Razzaque Ahmed
Oct 24, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ines BeyerAndré Lieber
Mar 3, 2009·Nature Clinical Practice. Rheumatology·Doruk Erkan, Michael D Lockshin
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Oct 7, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J ValencakM Raderer
Feb 9, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J C SoriaD Khayat
Feb 10, 2009·Retina·Sujit Itty, Jose S Pulido
Feb 26, 2010·Blood·Weihsu C ChenJames C Paulson
Jun 6, 2009·Journal of Biological Engineering·Yuning LeiPin Wang
Apr 10, 2013·Arthritis Research & Therapy·Stephan BlümlRonald Herbst
Jul 2, 2010·Journal of Oncology Practice·Jill Atmar
Feb 14, 2013·The Review of Diabetic Studies : RDS·Benno WeigmannCarolin Daniel
Jul 1, 2008·Biomedical Imaging and Intervention Journal·D E HeronJ W Mucenski
Oct 19, 2012·Radiology and Oncology·Brigita GregoricBarbara Jezersek Novakovic
Sep 8, 2009·Haematologica·Marieke GriffioenMirjam H M Heemskerk
Oct 26, 2013·The British Journal of Ophthalmology·Kelly L LarkinJustine R Smith
Mar 2, 2010·International Journal of Hematology·Davide BedognettiAndrea De Maria
Jul 30, 2014·Cancer Causes & Control : CCC·Qi Jie Nicholas LeoGertraud Maskarinec
Sep 10, 2014·Expert Review of Neurotherapeutics·Franz Josef HolzerChristian M Korff
Sep 19, 2009·Expert Review of Anticancer Therapy·Javier Briones
Feb 27, 2009·Expert Opinion on Drug Safety·Matthew C Winter, B W Hancock
Apr 2, 2014·British Journal of Haematology·Deepa Jayakody Arachchillage, Mike Greaves
Aug 19, 2014·Hematology·Yasuyuki AraiAkifumi Takaori-Kondo
Aug 9, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhanshan ChaBaohua Qian

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2021 Meta ULC. All rights reserved